Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Return on Capital Employed (2016 - 2025)

Tg Therapeutics has reported Return on Capital Employed over the past 10 years, most recently at 0.14% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.14% for Q4 2025, up 13.0% from a year ago — trailing twelve months through Dec 2025 was 0.14% (up 13.0% YoY), and the annual figure for FY2025 was 0.18%, up 17.0%.
  • Return on Capital Employed for Q4 2025 was 0.14% at Tg Therapeutics, up from 0.09% in the prior quarter.
  • Over the last five years, Return on Capital Employed for TGTX hit a ceiling of 0.37% in Q2 2024 and a floor of 1.43% in Q4 2022.
  • Median Return on Capital Employed over the past 5 years was 0.42% (2021), compared with a mean of 0.52%.
  • Biggest five-year swings in Return on Capital Employed: surged 203bps in 2021 and later plummeted -49bps in 2022.
  • Tg Therapeutics' Return on Capital Employed stood at 1.05% in 2021, then plummeted by -37bps to 1.43% in 2022, then soared by 105bps to 0.07% in 2023, then crashed by -85bps to 0.01% in 2024, then soared by 1166bps to 0.14% in 2025.
  • The last three reported values for Return on Capital Employed were 0.14% (Q4 2025), 0.09% (Q3 2025), and 0.1% (Q2 2025) per Business Quant data.